Genentech goes beyond Infinity with FDA OK to sell Hedgehog inhibitor for advanced BCC
31 January 2012
Daniel B. Moskowitz
Please Login to read the full article.
31 January 2012
Daniel B. Moskowitz
Please Login to read the full article.
RELATED CONTENT
NEWS
- US FDA to decide fate of Roche's basal cell carcinoma drug by March
- 2011 US submission for Genentech/Curis' vismodegib in basal cell carcinoma
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- Curis rises on Genentech US NDA submission for skin cancer drug
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
